InceptionR’s Transmedics TMDX Stock Holding History

InceptionR’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,552	Closed	-$286K	–	871
2025 Q3	$286K	Buy	+2,552	New	+$299K	0.07%	484

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

InceptionR's TMDX Position: Q4 2025 in Review

InceptionR sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 2,552 shares — an estimated $286K sold.

InceptionR first reported a position in TMDX in Q3 2025 and held it in 1 quarter. The position peaked at $286K in Q3 2025. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

InceptionR reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
InceptionR sold 2,552 Transmedics shares in Q4 2025, an estimated $286K.
InceptionR first reported a position in Transmedics in Q3 2025 and held it in 1 quarter.
InceptionR's Transmedics position peaked at $286K in Q3 2025.
428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on InceptionR's 13F filing for Q4 2025, filed 11 Feb 2026.